Most Anticipated Presentations: Vaccines Europe
In anticipation of our Vaccines Europe: In-Person event happening on 29-30 November 2022 in Berlin, Germany, we look at 3 of the most anticipated Industry presentations. Vaccines Europe is an intensive 2-day in-person conference that delves into the latest in vaccine research, platform technologies, analytics, and vaccine development.
A meeting place for experts working within cutting-edge vaccine research and development, presentations will delve into the different applications of vaccines in therapeutics.
From antibodies against infectious diseases and T cell vaccines to adapting vaccines against new variants and developing vaccines for antimicrobial resistance pathogens, Vaccines Europe will provide a unique opportunity to gain a comprehensive understanding of the current and future vaccines landscape.
With a high-quality program devised with the help of our esteemed advisory board, not-to-miss industry presentations include:
1.) ‘Plasmid: A Vaccine Platform 30 Years In The Making’
- Review of plasmid’s role in vaccines and other therapies (DNA vaccine, mRNA vaccine, gene therapy)
- Potential for plasmid as a platform
- Development of a scalable plasmid process to meet various needs
Matthew Watson, Principal Scientist, Merck & Co
2.) ‘New Developments In Plant-Made Vaccines’
- Production platforms for vaccines
- Plant-based protein expression for recombinant subunit vaccines
- Versatility: Individualized cancer vaccines (the MagnIcon (TM) experience)
- Speed: the bbola trivalent vaccine Zmap
- Scalability: Medicago’s COVID-19 vaccine
- New developments (ICON Genetics / Denka norovirus vaccine)
- Real and perceived hurdles / conclusions
John-Edward Butler-Ransohoff, Vice President, Open Innovation Public-Private Partnerships, Bayer AG
3.) ‘Adjuvanted Vaccines For Pandemic Response’
- Characteristics of an adjuvant for pandemic response vaccines
- Applications in influenza vaccines
- Application in SARS-CoV2 vaccines
Margherita Coccia, Technical Project Leader, New Adjuvants Discovery, GlaxoSmithKline
Over 300 senior attendees from leading pharmaceutical, biopharmaceutical, academics, CRO and solution provider companies will be attending Vaccines Europe: In-Person.
Sign up for the brochure HERE and register HERE today.
For more information on Oxford Global’s Biologics 2022 event series, visit: https://oxfordglobal.com/biologics/upcoming/
